Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
American Journal of Clinical Dermatology
Erschienen in: American Journal of Clinical Dermatology 5/2015

01.10.2015 | Systematic Review

Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review

verfasst von: Lucia Billeci, Alessandro Tonacci, Gennaro Tartarisco, Liliana Ruta, Giovanni Pioggia, Sebastiano Gangemi

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Atopic dermatitis (AD) is an allergic disorder caused by both immunological dysregulation and epidermal barrier defect. Several studies have investigated the association between AD and mental health disorders. Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental conditions characterized by impairments in social communication and restricted, stereotyped interests and behaviors. The concurrent increased prevalence of AD and ASD in the last decades has led many scientists to investigate the relationship between the two diseases.

Objective

The aim of this systematic review was to examine the association between AD and ASD.

Methods

A systematic review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. PubMed and ScienceDirect were searched up to March 2015 for all reports examining the association between ASD and AD. Descriptive statistics of the studies are reported.

Results

The review included 18 studies assessing the association between ASD and AD. Of these studies, two focused on ASD in relation to AD alone, 14 discussed ASD in relation to both AD and other atopic disorders, and two evaluated AD in parents of children with ASD. Most of these studies found a positive association between the two disorders, although there were some studies going in the opposite direction. The entity of the association is somewhat inconsistent among the different studies given that the frequencies of AD in ASD compared with a control group ranged from 7 to 64.2 %. In addition, odds ratios (ORs) or hazard ratios (HRs) gave different results as three studies found a weak association with an OR below 2 and a nonsignificant p value, and three other studies found a moderate or strong association with an OR ranging from 1.52 to 7.17 and a significant p value. When all atopic disorders were considered when evaluating the risk of ASD, the association was strong with an HR of 3.4 or an OR of 1.24 and p < 0.001.

Conclusions

Overall, the results of this systematic review seem to reveal an association between ASD and AD, suggesting that subjects with ASD have an increased risk of presenting with AD compared with typically developing controls, and vice versa. This association is supported by clinical/epidemiological aspects, shared genetic background and common immunological and autoimmune processes. However, the variability in study population and design, and the presence of other risk factors acting as confounding factors, sometimes contribute to inconsistent results. Further studies are needed to clarify the underlying pathophysiologic mechanism explaining the association between ASD and AD and to explore the causal association between the two conditions.
Literatur
1.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
2.
Matson JL, Kozlowski AM. Autistic regression. Res Autism Spectr Disord. 2010;4:340–5.CrossRef
3.
Zappella M. Autistic regression with and without EEG abnormalities followed by favourable outcome. Brain Dev. 2010;32(9):739–45.PubMedCrossRef
4.
5.
Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature. 2009;461(7265):802–8.PubMedCentralPubMedCrossRef
6.
Herbert MR. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol. 2010;23(2):103–10.PubMedCrossRef
7.
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders: autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61(3):1–19.
8.
Blumberg SJ, Bramlett MD, Kogan MD, Schieve LA, Jones JR, Lu MC. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011–2012. Natl Health Stat Report. 2013;65:1–11.PubMed
9.
Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, ISAAC Phase Three Study Group, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross sectional surveys. Lancet. 2006;368:733–43.PubMedCrossRef
10.
Schernhammer ES, Vutuc C, Waldhör T, Haidinger G. Time trends of the prevalence of asthma and allergic disease in Austrian children. Pediatr Allergy Immunol. 2008;19:125–31.PubMedCrossRef
11.
Garg N, Silverberg JI. Epidemiology of childhood atopic dermatitis. Clin Dermatol. 2015;33(3):281–8.PubMedCrossRef
12.
Jackson KD, Howie LD, Akinbami LJ. Trends in allergic conditions among children: United States, 1997–2011. NCHS Data Brief. 2013;121:1–8.PubMed
13.
Hansen TE, Evjenth B, Holt J. Increasing prevalence of asthma, allergic rhinoconjunctivitis and eczema among schoolchildren: three surveys during the period 1985–2008. Acta Paediatr. 2013;102:47–52.PubMedCrossRef
14.
15.
16.
Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 2010;105(2):99–106.PubMedCrossRef
17.
Zheng T, Yu J, Oh MH, Zhu Z. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res. 2011;3(2):67–73.PubMedCentralPubMedCrossRef
18.
Darlenski R, Kazandjieva J, Hristakieva E, Fluhr JW. Atopic dermatitis as a systemic disease. Clin Dermatol. 2014;32(3):409–13.PubMedCrossRef
19.
Morar N, Willis-Owen SA, Moffatt MF, Cookson WO. The genetics of atopic dermatitis. J Allergy Clin Immunol. 2006;118:24–34.PubMedCrossRef
20.
Simpson EL. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin. 2010;26(3):633–40.PubMedCrossRef
21.
Schram ME, Tedja AM, Spijker R, Bos JD, Williams HC, Spuls PI. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol. 2010;162(5):964–73.PubMedCrossRef
22.
Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med. 1992;175:1285–90.PubMedCrossRef
23.
Bieber T, Novak N. Pathogenesis of atopic dermatitis: new developments. Curr Allergy Asthma Rep. 2009;9:291–4.PubMedCrossRef
24.
Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss of function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441–6.PubMedCrossRef
25.
26.
Brunsting LA. Atopic dermatitis (disseminated neurodermatitis) of young adults. Analysis of precipitating factors in one hundred and one cases and report of ten cases with associated juvenile cataract. Arch Dermatol Syphilol. 1936;34(6):935–57.CrossRef
27.
Chamlin SL. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther. 2006;19(2):104–7.PubMedCrossRef
28.
Faulstich ME, Williamson DA, Duchmann EG, Conerly SL, Brantley PJ. Psychophysiological analysis of atopic dermatitis. J Psychosom Res. 1985;29(4):415–7.PubMedCrossRef
29.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J. 2009;339:b2700.CrossRef
30.
31.
Adil H, Siegfried E, Armbrecht E. The impact of severe atopic dermatitis: analysis of comorbidities. J Am Acad Dermatol. 2014;70(5):AB66.
32.
Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol. 2006;172(1–2):198–205.PubMedCrossRef
33.
Jyonouchi H, Geng L, Ruby A, Reddy C, Zimmerman-Bier B. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr. 2005;146(5):605–10.PubMedCrossRef
34.
Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H. Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflamm. 2008;5:52.CrossRef
35.
Mostafa GA, Hamza RT, El-Shahawi HH. Allergic manifestations in autistic children: relation to disease severity. J Pediatr Neurol. 2008;6(2):115–23.
36.
Mostafa GA, El-Sherif D, Hamza RT, Shehab A. Hyperserotonemia in Egyptian autistic children: relation to allergic manifestations. J Pediatr Neurol. 2008;6(3):227–36.
37.
Mostafa GA, Al-Ayadhi LY. The possible relationship between allergic manifestations and elevated serum levels of brain specific auto-antibodies in autistic children. J Neuroimmunol. 2013;261(1–2):77–81.PubMedCrossRef
38.
Magalhães ES, Pinto-Mariz F, Bastos-Pinto S, Pontes AT, Prado EA, deAzevedo LC. Immune allergic response in Asperger syndrome. J Neuroimmunol. 2009;216(1–2):108–12.PubMedCrossRef
39.
Zerbo O, Leong A, Barcellos L, Bernal P, Fireman B, Croen LA. Immune mediated conditions in autism spectrum disorders. Brain Behav Immun. 2015;46:232–6.PubMedCrossRef
40.
Garg N, Silverberg JI. Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. Ann Allergy Asthma Immunol. 2014;112(6):525–32.PubMedCrossRef
41.
Schieve LA, Gonzalez V, Boulet SL, Visser SN, Rice CE, Van Naarden Braun K, et al. Concurrent medical conditions and health care use and needs among children with learning and behavioral developmental disabilities, National Health Interview Survey, 2006–2010. Res Dev Disabil. 2012;33(2):467–76.PubMedCrossRef
42.
Shibata A, Hitomi Y, Kambayashi Y, Hibino Y, Yamazaki M, Mitoma J, et al. Epidemiological study on the involvements of environmental factors and allergy in child mental health using the Autism Screening Questionnaire. Res Autism Spectr Disord. 2013;7(1):132–40.CrossRef
43.
Chen MH, Su T, Chen Y, Hsu J, Huang K, Chang W, et al. Comorbidity of allergic and autoimmune diseases in patients with autism spectrum disorder: a nationwide population-based study. Res Autism Spectr Disord. 2013;7(2):205–12.CrossRef
44.
Chen MH, Su TP, Chen YS, Hsu JW, Huang KL, Chang WH, et al. Attention deficit hyperactivity disorder, tic disorder, and allergy: is there a link? A nationwide population-based study. J Child Psychol Psychiatry. 2013;54(5):545–51.PubMedCrossRef
45.
Lin TY, Lin PY, Su TP, Chen YS, Hsu JW, Huang KL, et al. Autistic spectrum disorder, attention deficit hyperactivity disorder, and allergy: is there a link? A nationwide study. Res Autism Spectr Disord. 2014;8(10):1333–8.CrossRef
46.
Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med. 2005;159(2):151–7.PubMed
47.
Larsson M, Weiss B, Janson S, Sundell J, Bornehag CG. Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6–8 years of age. Neurotoxicology. 2009;30(5):822–31.PubMedCentralPubMedCrossRef
48.
Burgess NK, Sweeten TL, McMahon WM, Fujinami RS. Hyperserotoninemia and altered immunity in autism. J Autism Dev Disord. 2006;36(5):697–704.PubMedCrossRef
49.
Laughter D, Istvan J, Tofte S, Hanifin J. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol. 2000;43(4):649–55.PubMedCrossRef
50.
Krämer U, Schäfer T, Behrendt H, Ring J. The influence of cultural and educational factors on the validity of symptom and diagnosis questions for atopic eczema. Br J Dermatol. 1998;139(6):1040–6.PubMedCrossRef
51.
Wing L. Sex ratios in early childhood autism and related conditions. Psychiatry Res. 1981;5(2):129–37.PubMedCrossRef
52.
53.
54.
Lauritsen MB, Pedersen CB, Mortensen PB. Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study. J Child Psychol Psychiatry. 2005;46(9):963–71.PubMedCrossRef
55.
Burke HL, Yeo RA, Vranes L, Garry PJ, Goodwin JS. Handedness, developmental disorders, and in vivo and in vitro measurements of immune responses. Dev Neuropsychol. 1988;4(2):103–15.CrossRef
56.
Flannery KA, Liederman J. Is there really a syndrome involving the co-occurrence of neurodevelopmental disorder talent, non-right handedness and immune disorder among children? Cortex. 1995;31(3):503–15.PubMedCrossRef
57.
Geschwind N, Galaburda AM. Cerebral lateralization: biological mechanisms, associations, and pathology. I: a hypothesis and a program for research. Arch Neurol. 1985;42(5):428–59.PubMedCrossRef
58.
Geschwind N, Galaburda AM. Cerebral lateralization: biological mechanisms, associations, and pathology. II: a hypothesis and a program for research. Arch Neurol. 1985;42(5):521–52.PubMedCrossRef
59.
Geschwind N, Galaburda AM. Cerebral lateralization: biological mechanisms, associations, and pathology. III: a hypothesis and a program for research. Arch Neurol. 1985;42(5):634–54.PubMedCrossRef
60.
61.
Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry. 2007;12(1):2–22.PubMedCrossRef
62.
Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, et al. Most genetic risk for autism resides with common variation. Nat Genet. 2014;46(8):881–5.PubMedCentralPubMedCrossRef
63.
64.
Schultz Larsen FV, Holm NV. Atopic dermatitis in a population based twin series. Concordance rates and heritability estimation. Acta Derm Venereol Suppl (Stockh). 1985;114:159.
65.
Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population based twin sample. J Am Acad Dermatol. 1986;15(5 Pt 1):487–494.
66.
Strachan DP, Wong HJ, Spector TD. Concordance and interrelationship of atopic diseases and markers of allergic sensitization among adult female twins. J Allergy Clin Immunol. 2001;108(6):901–7.PubMedCrossRef
67.
van Beijsterveldt CE, Boomsma DI. Genetics of parentally reported asthma, eczema and rhinitis in 5-yr-old twins. Eur Respir J. 2007;29(3):516–21.PubMedCrossRef
68.
McGirt LY, Beck LA. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol. 2006;118:202–8.PubMedCrossRef
69.
70.
Tamauchi H, Terashima M, Ito M, Maruyama H, Ikewaki N, Inoue M, et al. Evidence of GATA-3-dependent Th2 commitment during the in vivo immune response. Int Immunol. 2004;16:179–87.PubMedCrossRef
71.
Moriguchi T, Takako N, Hamada M, Maeda A, Fujioka Y, Kuroha T, et al. Gata3 participates in a complex transcriptional feedback network to regulate sympathoadrenal differentiation. Development. 2006;133:3871–81.PubMedCrossRef
72.
Tsarovina K, Pattyn A, Stubbusch J, Muller F, van der Wees J, Schneider C, et al. Essential role of Gata transcription factors in sympathetic neuron development. Development. 2004;131:4775–86.PubMedCrossRef
73.
Trottier G, Srivastava L, Walker CD. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci. 1999;24:103–15.PubMedCentralPubMed
74.
Rout UK, Clausen P. Common increase of GATA-3 level in PC-12 cells by three teratogens causing autism spectrum disorders. Neurosci Res. 2009;64(2):162–9.PubMedCrossRef
75.
Connors SL, Crowell DE, Eberhart CG, Copeland J, Newschaffer CJ, Spence SJ, et al. Beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. J Child Neurol. 2005;20(11):876–84.PubMedCrossRef
76.
Cheslack-Postava K, Fallin MD, Avramopoulos D, Connors SL, Zimmerman AW, Eberhart CG, et al. Beta2-adrenergic receptor gene variants and risk for autism in the AGRE cohort. Mol Psychiatry. 2007;12(3):283–91.PubMed
77.
Roguedas AM, Audrezet MP, Scotet V, Dupré-Goetghebeur D, Ferec C, Misery L. Intrinsic atopic dermatitis is associated with a beta-2 adrenergic receptor polymorphism. Acta Derm Venereol. 2006;86(5):447–8.PubMedCrossRef
78.
Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci. 1996;93(15):7849–54.PubMedCentralPubMedCrossRef
79.
Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis. 2005;41(7):S513–9.PubMedCrossRef
80.
Mizue Y, Ghani S, Leng L, McDonald C, Kong P, Baugh J, et al. Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci. 2005;102(40):14410–5.PubMedCentralPubMedCrossRef
81.
Yasuda C, Enomoto A, Ishiwatari S, Mori N, Kagoyama K, Matsunaga K, et al. Macrophage migration inhibitory factor (MIF) in the stratum corneum: a marker of the local severity of atopic dermatitis. Exp Dermatol. 2014;23(10):764–6.PubMedCrossRef
82.
83.
Tonacci A, Borghini A, Mercuri A, Pioggia G, Andreassi MG. Brain-derived neurotrophic factor (Val66Met) polymorphism and olfactory ability in young adults. J Biomed Sci. 2013;20:57.PubMedCentralPubMedCrossRef
84.
Halepoto DM, Bashir S, Al-Ayadhi L. Possible role of brain-derived neurotrophic factor (BDNF) in autism spectrum disorder: current status. J Coll Physicians Surg Pak. 2014;24(4):274–8.PubMed
85.
Chen CP, Lin SP, Chern SR, Tsai FJ, Wu PC, Lee CC, et al. A de novo 7.9 Mb deletion in 22q13.2 → qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings. Eur J Med Genet. 2010;53(5):329–32.PubMedCrossRef
86.
Redecker P, Bockmann J, Böckers TM. Expression of postsynaptic density proteins of the ProSAP/Shank family in the thymus. Histochem Cell Biol. 2006;126:679–85.PubMedCrossRef
87.
Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet. 2007;81:1289–97.PubMedCentralPubMedCrossRef
88.
Sehra S, Holbreich M, Kaplan MH, Barbé Tuana FM, Mousdicas N, Travers JB. Clinical correlations of recent developments in the pathogenesis of atopic dermatitis. An Bras Dermatol. 2008;83(1):57–73.CrossRef
89.
Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology. 2000;45(1):1–6.CrossRef
90.
Wei H, Zou H, Sheikh AM, Malik M, Dobkin C, Brown WT, Li X. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflammation 2011;8:52.PubMedCentralPubMedCrossRef
91.
Singh VK, Warren RP, Odell JD, Cole P. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin Immunol Immunopathol. 1991;61(3):448–55.PubMedCrossRef
92.
Ishiuji Y, Coghill RC, Patel TS, Oshiro Y, Kraft RA, Yosipovitch G. Distinct patterns of brain activity evoked by histamine induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol. 2009;161(5):1072–80.PubMedCentralPubMedCrossRef
93.
Yarlagadda A, Alfson E, Clayton AH. The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont). 2009;6(11):18–22.
94.
95.
Theoharides TC, Angelidou A, Alysandratos KD, Zhang B, Asadi S, Francis K, et al. Mast cell activation and autism. Biochim Biophys Acta. 2012;1822(1):34–41.PubMedCrossRef
96.
Theoharides TC. Is a subtype of autism an allergy of the brain? Clin Ther. 2013;35(5):584–91.PubMedCrossRef
97.
McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics. 2014;133:872–83.PubMedCrossRef
98.
Grubišić V, Kennedy AJ, Sweatt JD, Parpura V. Pitt-Hopkins mouse model has altered particular gastrointestinal transits in vivo. Autism Res. 2015. doi:10.​1002/​aur.​1467.PubMed
99.
Muszer M, Noszczyńska M, Kasperkiewicz K, Skurnik M. Human microbiome: when a friend becomes an enemy. Arch Immunol Ther Exp (Warsz). 2015;63(4):287–98.CrossRef
100.
Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, et al. Staphylococcus epidermidisesp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465:346–9.PubMedCrossRef
101.
Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850–9.PubMedCentralPubMedCrossRef
102.
Stecher B, Chaffron S, Käppeli R, Hapfelmeier S, Freedrich S, Weber TC, et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog. 2010;6(1):e1000711.PubMedCentralPubMedCrossRef
103.
Lucarelli S, Frediani T, Zingoni AM, Ferruzzi F, Giardini O, Quintieri F, et al. Food allergy and infantile autism. Panminerva Med. 1995;37:137–41.PubMed
104.
Chambers ES, Suwannasaen D, Mann EH, Urry Z, Richards DF, Lertmemongkolchai G, et al. 1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3+ regulatory T cells through preferential expansion and usage of interleukin-2. Immunology. 2014;143(1):52–60.PubMedCentralPubMedCrossRef
105.
Pioggia G, Tonacci A, Tartarisco G, Billeci L, Muratori F, Ruta L, et al. Autism and lack of D3 vitamin: a systematic review. Res Autism Spectr Disord. 2014;8(12):1685–98.CrossRef
106.
Jia F, Wang B, Shan L, Xu Z, Staal WG, Du L. Core symptoms of autism improved after vitamin D supplementation. Pediatrics. 2015;135(1):e196–8.PubMedCrossRef
107.
Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol. 2013;34:47–64.PubMedCrossRef
108.
Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol. 2003;49:277–300.PubMed
109.
Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln LR, Burrell A, et al. A ChIP-seq-defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010;20:1352–60.PubMedCentralPubMedCrossRef
110.
Ehlayel MS, Bener A, Sabbah A. Is high prevalence of vitamin D deficiency evidence for asthma and allergy risks? Eur Ann Allergy Clin Immunol. 2011;43:81–8.PubMed
111.
Benson AA, Toh JA, Vernon N, Jariwala SP. The role of vitamin D in the immunopathogenesis of allergic skin diseases. Allergy. 2012;67:296–301.PubMedCrossRef
112.
Kanda N, Hau CS, Tada Y, Sato S, Watanabe S. Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M. Allergy. 2012;67(6):804–12.PubMedCrossRef
113.
Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770–3.PubMedCrossRef
114.
Kokkonen J, Niinimaki A. Increased incidence of autoimmune disorders as a late complication in children with early onset dermatitis and/or milk allergy. J Autoimmun. 2004;22(4):341–4.PubMedCrossRef
115.
Mittermann I, Aichberger KJ, Bunder R, Mothes N, Renz H, Valenta R. Autoimmunity and atopic dermatitis. Curr Opin Allergy Clin Immunol. 2004;4(5):367–71.PubMedCrossRef
116.
Ashwood P, Van de Water J. Is autism an autoimmune disease? Autoimmun Rev. 2004;3(7–8):557–62.PubMedCrossRef
117.
118.
Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun. 1993;7(1):97–103.PubMedCrossRef
119.
Singh VK, Warren R, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol. 1997;17(1):88–90.PubMedCrossRef
120.
Singh VK, Rivas WH. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci Lett. 2004;355(1–2):53–6.PubMedCrossRef
121.
Singh VK, Lin SX, Yang VC. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol. 1998;89(1):105–8.PubMedCrossRef
122.
Mostafa GA, El-Sayed ZA, El-Aziz MM, El-Sayed MF. Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J Child Neurol. 2008;23(12):1413–8.PubMedCrossRef
123.
Mostafa GA, Al-Ayadhi LY. The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism. J Neuroinflamm. 2011;8:180.CrossRef
124.
Mostafa GA, Al-Ayadhi LY. Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J Neuroinflamm. 2011;8:39.CrossRef
125.
Dochniak MJ. Autism spectrum disorders: exogenous protein insult. Med Hypotheses. 2007;69(3):545–9.PubMedCrossRef
126.
127.
Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A [published erratum appears in J Neuroimmunol 2002;130(1–2):248]. J Neuroimmunol. 2002;129(1–2):168–77.PubMedCrossRef
128.
Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology. 2002;46(2):76–84.PubMedCrossRef
129.
Mutter J, Naumann J, Schneider R, Walach H, Haley B. Mercury and autism: accelerating evidence? Neuro Endocrinol Lett. 2005;26(5):439–46.PubMed
Metadaten
Titel
Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review
verfasst von
Lucia Billeci
Alessandro Tonacci
Gennaro Tartarisco
Liliana Ruta
Giovanni Pioggia
Sebastiano Gangemi
Publikationsdatum
01.10.2015
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 5/2015
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-015-0145-5

Weitere Artikel der Ausgabe 5/2015

American Journal of Clinical Dermatology 5/2015 Zur Ausgabe

Review Article

The Dermatological Manifestations of Postural Tachycardia Syndrome: A Review with Illustrated Cases

Systematic Review

Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review

Original Research Article

Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case–Control Study

Systematic Review

Treatment of Primary Craniofacial Hyperhidrosis: A Systematic Review

Review Article

Treating Psoriasis During Pregnancy: Safety and Efficacy of Treatments

Review Article

The Infectious and Noninfectious Dermatological Consequences of Flooding: A Field Manual for the Responding Provider

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

16.04.2024 | DGIM 2024 | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

12.04.2024 | Vitiligo | Nachrichten

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt
weitere anzeigen

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise